Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 6, 2025 • 12:51 PM ET

Date/Time Source News Release
06/05/2023 07:00 AM EDT GlobeNewswire Bellerophon Announces Top-Line Data from Phase 3 REBUILD Clinical Trial of INOpulse® for Treatment of Fibrotic Interstitial Lung Disease
05/15/2023 04:50 PM EDT GlobeNewswire Bellerophon Provides Clinical Program Update and Reports First Quarter 2023 Financial Results
05/11/2023 08:30 AM EDT GlobeNewswire Bellerophon Therapeutics Announces Last Patient Has Completed Blinded Treatment in Phase 3 REBUILD Study for INOpulse® in Fibrotic Interstitial Lung Disease
03/31/2023 08:30 AM EDT GlobeNewswire Bellerophon Provides Clinical Program Update and Reports Full-Year 2022 Financial Results
03/06/2023 08:30 AM EST GlobeNewswire Bellerophon Therapeutics Announces $5 Million Registered Direct Offering
02/09/2023 08:30 AM EST GlobeNewswire Bellerophon Therapeutics Receives IND Clearance from China NMPA to Conduct Phase 3 Clinical Trial in China for INOpulse® in Fibrotic Interstitial Lung Disease
01/18/2023 04:05 PM EST GlobeNewswire Bellerophon Therapeutics Announces Completion of Enrollment in Phase 3 REBUILD Study for INOpulse® in Fibrotic Interstitial Lung Disease
01/05/2023 08:30 AM EST GlobeNewswire Bellerophon Therapeutics Announces License Agreement for the Commercialization of INOpulse® in Greater China with Baylor BioSciences
11/14/2022 08:30 AM EST GlobeNewswire Bellerophon Provides Clinical Program Update and Reports Third Quarter 2022 Financial Results
09/27/2022 08:30 AM EDT GlobeNewswire Bellerophon Announces FDA Acceptance of Change to Ongoing Phase 3 REBUILD Study of INOpulse® for Treatment of Fibrotic Interstitial Lung Disease
Page

Additional News

As of June 6, 2025 • 12:51 PM ET

Date/Time Source News Release
12/17/2024 06:00 AM EST US Earnings Reports Expected US Company Earnings on Tuesday, December 17th, 2024
12/17/2024 04:31 AM EST US Earnings Reports Expected earnings - Bellerophon Therapeutics Inc.
12/10/2024 06:00 AM EST US Earnings Reports Expected US Company Earnings on Tuesday, December 10th, 2024
12/10/2024 04:31 AM EST US Earnings Reports Expected earnings - Bellerophon Therapeutics Inc.
12/03/2024 06:00 AM EST US Earnings Reports Expected US Company Earnings on Tuesday, December 3rd, 2024
12/03/2024 04:31 AM EST US Earnings Reports Expected earnings - Bellerophon Therapeutics Inc.
11/19/2024 06:00 AM EST US Earnings Reports Expected US Company Earnings on Tuesday, November 19th, 2024
11/19/2024 04:45 AM EST US Earnings Reports Expected earnings - Bellerophon Therapeutics Inc.
11/13/2024 04:45 AM EST US Earnings Reports Expected earnings - Bellerophon Therapeutics Inc.
09/30/2024 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Monday, September 30th, 2024
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.